• Home
  • About
  • Pipeline
  • Platform
  • News
Mobile Menu
  • Second Genome - The Microbiome Company
  • Home
  • About
    • Our Story
    • Leadership
    • Board
    • Advisors
    • Strategic Partnerships
  • Pipeline
    • Disease Focus Areas
  • Platform
    • Data Generation
    • Data Processing
    • Nomination & Lead Prioritization
    • Classic Drug Development
    • Microbiome Technologies
    • Data Analysis Tools
  • News
    • Publications
    • Events
    • Posters

Microbiome to Medicine®

Second Genome is a clinical stage pharmaceutical company with a mission to redefine disease in the context of microbiome medicine. We leverage our proprietary drug discovery platform to identify effective peptides, proteins and small molecule therapeutics that can address unmet medical needs.

Discover More

Platform

Second Genome's proprietary Microbiome Discovery Platform uniquely addresses current limitations in target discovery and validation by integrating computational science, machine learning with human disease biology to redefine diseases, and generate libraries of compounds that are screened in traditional drug discovery and development assays.

Learn More

Pipeline

Our lead clinical program, SGM-1019, targets inflammatory pathways identified in both NASH and IBD, offering the potential for a novel, safe and well-tolerated oral therapy for the treatment of these diseases.

Learn More

News

January 23, 2019

Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For The Treatment Of Nonalcoholic Steatohepatitis (NASH)

September 26, 2018

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer

July 31, 2018

Second Genome Certified as Great Place to Work®

July 23, 2018

Second Genome Appoints Anupama S. Hoey as Chief Business Officer

April 9, 2018

Second Genome Presents Clinical and Preclinical Data Supporting Development of Its P2X7 Inhibitor, SGM-1019, in NASH at the EASL International Liver Congress 2018

See All News

Second Genome Therapeutics

  • About
  • Pipeline
  • Platform
  • News

social-linkedin.pngsocial-facebook.pngsocial-twitter.png

Contact Us

341 Allerton Avenue
South San Francisco, CA 94080
partnering@secondgenome.com
(650) 440-4606

Copyright © 2019All rights reserved.